Engineer receives $1.5M grant for nanoparticle cancer research

June 30, 2008

AUSTIN, Texas -A biomedical engineering assistant professor at The University of Texas at Austin has been awarded a $1.5 million National Institutes of Health/National Cancer Institute grant to conduct nanoparticle cancer research.

Grant recipient James Tunnell says the five-year project will include collaboration with other researchers from the university, M.D. Anderson Cancer Center in Houston and the University of California at Irvine.

The project will focus on the development of molecular imaging technologies for the screening, diagnosis and therapy of cancer. Recent advancements in nanotechnologies have produced a class of optically active metal particles with highly desirable molecular and optical properties suitable for detection and treatment.

"We will design nanoparticles that can be injected into the bloodstream where they will seek out and attach themselves to cancer cells within the body," Tunnell says. "In this case, the particles themselves are identifying the cancer cells, and we can then image the nanoparticles in order to find the cancer."

Using weak levels of light, the particles act as imaging agents making it possible to locate cancer cells. Then, higher light levels can be used to heat the same particles, killing the cancer cells while leaving nearby healthy cells unharmed.

"Our goal is to detect and treat cancer at the cellular level and at its earliest stage when survival rates are highest," Tunnell says.
-end-
The collaborators on the project include the university's Brian Korgel, chemical engineering professor, and Pengyu Ren, biomedical engineering assistant professor; M.D. Anderson's Sunil Krishnan and the University of California at Irvine's Anthony Durkin and David Cuccia.

University of Texas at Austin

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.